[go: up one dir, main page]

AU5110896A - Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women - Google Patents

Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women

Info

Publication number
AU5110896A
AU5110896A AU51108/96A AU5110896A AU5110896A AU 5110896 A AU5110896 A AU 5110896A AU 51108/96 A AU51108/96 A AU 51108/96A AU 5110896 A AU5110896 A AU 5110896A AU 5110896 A AU5110896 A AU 5110896A
Authority
AU
Australia
Prior art keywords
perimenopausal
month
injection
once
replacement therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU51108/96A
Other versions
AU713258B2 (en
Inventor
Semiramis Aydinlik
Ursula Lachnit-Fixson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU5110896A publication Critical patent/AU5110896A/en
Application granted granted Critical
Publication of AU713258B2 publication Critical patent/AU713258B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU51108/96A 1995-03-16 1996-03-15 Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women Ceased AU713258B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19510861A DE19510861A1 (en) 1995-03-16 1995-03-16 One-month injection as a depot contraceptive and for hormone replacement therapy for peri- and premenopausal women
DE19510861 1995-03-16
PCT/EP1996/001201 WO1996028165A1 (en) 1995-03-16 1996-03-15 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women

Publications (2)

Publication Number Publication Date
AU5110896A true AU5110896A (en) 1996-10-02
AU713258B2 AU713258B2 (en) 1999-11-25

Family

ID=7757668

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51108/96A Ceased AU713258B2 (en) 1995-03-16 1996-03-15 Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women

Country Status (17)

Country Link
EP (1) EP0814811A1 (en)
JP (1) JPH11501649A (en)
KR (1) KR19980703058A (en)
AR (1) AR002283A1 (en)
AU (1) AU713258B2 (en)
CA (1) CA2215382A1 (en)
CZ (1) CZ289697A3 (en)
DE (1) DE19510861A1 (en)
HU (1) HUP9801691A3 (en)
IL (1) IL117516A (en)
MX (1) MX9707009A (en)
NO (1) NO974255L (en)
NZ (1) NZ304027A (en)
PL (1) PL322202A1 (en)
SK (1) SK123997A3 (en)
WO (1) WO1996028165A1 (en)
ZA (1) ZA962177B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
KR20250142811A (en) * 2024-03-22 2025-09-30 주식회사 에아스텍 Use of Norethisterone enanthate compound for preventing or treating a cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Also Published As

Publication number Publication date
DE19510861A1 (en) 1996-09-19
AR002283A1 (en) 1998-03-11
KR19980703058A (en) 1998-09-05
JPH11501649A (en) 1999-02-09
ZA962177B (en) 1996-07-29
EP0814811A1 (en) 1998-01-07
SK123997A3 (en) 1998-02-04
CZ289697A3 (en) 1997-12-17
IL117516A0 (en) 1996-07-23
PL322202A1 (en) 1998-01-19
NO974255L (en) 1997-11-14
MX9707009A (en) 1997-11-29
IL117516A (en) 2000-07-26
NO974255D0 (en) 1997-09-15
AU713258B2 (en) 1999-11-25
NZ304027A (en) 2000-05-26
HUP9801691A3 (en) 1999-03-01
CA2215382A1 (en) 1996-09-19
WO1996028165A1 (en) 1996-09-19
HUP9801691A2 (en) 1998-11-30

Similar Documents

Publication Publication Date Title
CA2157003A1 (en) Hormone replacement therapy
US5460820B1 (en) Method for providing testosterone and optionally estrogen replacement therapy to women
AU3841093A (en) Applicator for introducing a cream-type susbstance into a woman's vagina
HUP9802608A3 (en) Hormone replacement therapy method and hormone dispenser
CA2218714A1 (en) Dosage form comprising oxybutynin
AU2862295A (en) Multi-vitamin and mineral supplements for women
AU3525893A (en) Valve and operator therefor
AU3841193A (en) Facial tissue dispensing carton
HUP9900301A3 (en) Hormone patch
AU1868595A (en) Human growth hormone
IL116743A0 (en) Pharmaceutical composition comprising a growth hormone
HUS1200002I1 (en) Hormonal composition consisting of an oestrogen compound and of a progestational compound
AU6431496A (en) A new skin preparation composition
AU4558393A (en) Ovulation inhibitor for hormonal contraception
AU1819897A (en) Medicinal prophylactic "trisan"
ZA959313B (en) A delivery system for agents and composition
AU4775693A (en) Peptide medicaments for treating disease
AU6367496A (en) New hormonal medicaments and their use for the correction of oestrogenic deficiencies
AU1942995A (en) New use of growth hormone
AU5110896A (en) Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women
AU2587195A (en) Growth hormone therapy and related methods and pharmaceutical compositions
AU2224195A (en) Medicinal composition for treating tardive dyskinesia and utilization thereof
AU3536895A (en) A new human peptide antibiotic (fall-39) and its use
PL319686A1 (en) Compressor's discharge valve
IL116742A0 (en) Pharmaceutical composition comprising a growth hormone

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired